STRATEGY - DRACONIS PHARMA
18
page-template-default,page,page-id-18,ajax_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-1.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.7,vc_responsive

Company

Strategy

Draconis Pharma S.L. is focused on providing scientific and technological services to pharmaceutical and biotechnology companies, aimed at supporting drug discovery at different stages of research, such as target validation, hit-finding, hit-to-lead and lead optimization towards the release of a robust and well-characterized preclinical candidate. Our scientific team comes entirely from the pharmaceutical R&D industry. They offer Draconis Pharma wide and proven experience in the different areas within drug discovery such as medicinal chemistry, analytical profiling, cell-based assays, in-vivo efficacy, ADME & PK and preliminary studies to determine toxicity and safety profiles.

 

Besides the service business, Draconis Pharma also participates in consortium and projects for the discovery and development of innovative technology or novel therapies for the treatment of inflammatory diseases and related disorders, such as Cancer.

Leitat_2014_0009

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR
Aviso de cookies